KATHERINE MONDADA: Open Payments
NPI 1598231623 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 22 payments from 16 companies in 2025. Trend: 2023 $1,165 · 2024 $1,618 · 2025 $1,866
Food & beverage: $1,813Education: $53
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $310 |
| Tempus AI, Inc | 3 | $240 |
| Sumitomo Pharma America, Inc. | 2 | $175 |
| Daiichi Sankyo Inc. | 2 | $138 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Exelixis Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Kite Pharma, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
Products named: RYBREVANT, XT CDX, ORGOVYX, LIBTAYO, ZEPZELCA, CABOMETYX, EPKINLY, Yescarta.
Industry payments across ID — which companies pay providers there.
